Timothy P. Gauthier, Pharm.D., BCPS, BCIDP is a pharmacist trained in infectious diseases and antimicrobial stewardship. He is a clinician, researcher, educator, and author. He is an advocate for antimicrobial stewardship and pharmacy education. Dr. Gauthier graduated from Northeastern University’s School of Pharmacy (Boston, MA) in 2008. He then completed a Post-Graduate Year-1 Pharmacy Practice Residency and a Post-Graduate …| IDStewardship
In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted December 2024 If you cannot measure it, you cannot determine if you have changed it. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the …| IDStewardship
In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS, BCIDP Article Construction by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP 2024 has been an interesting year for infectious disease literature dissemination. For years many of us were using #IDtwitter to get our journal article identification and discussion fix. With …| IDStewardship
In this article an infectious diseases pharmacist with 20+ years of experience in the profession discusses 5 quick things to know about drug shortages. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the July 2024 IDstewardship Newsletter 1. Not all drug “shortages” are created equal When someone says there …| IDStewardship
In this article an infectious diseases pharmacist discusses 5 neat things from the world of antimicrobials – let’s get nerdy! Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the September 2024 IDstewardship Newsletter 1. Echinocandins are associated with a paradoxical effect Giving more drug leads to less fungal killing? …| IDStewardship
In this article an infectious diseases pharmacist discusses 5 examples where challenging antibiotic workflows can be an issue. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the October 2024 IDstewardship Newsletter 1. The time it takes to make a dose of Amphotericin B Not giving Ambisome today but …| IDStewardship
Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 30 September 2024 I recently had the honor to give a key note speech for my alma matter, Northeastern University in Boston, MA. It took me a while to put the thoughts together and I had some support from my friend Dr. Robert Kraljevich. It …| IDStewardship
This text and table is intended for use as a study tool to assist people learning pharmacotherapy of common bacterial infections. Basic information on antibiotic spectrum of activity, FDA-approved indications, and a study table comparing ceftaroline and ceftobiprole is provided. Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., PharmD, BCPS, BCIDP, …| IDStewardship
In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., PharmD, BCPS, BCIDP, AAHIV-M Disclaimer: This text and table is intended for use as a study tool to assist people learning pharmacotherapy of recurrent Clostridioides …| IDStewardship
